mRNA vaccine development during the COVID-19 pandemic: a retrospective review from the perspective of the Swiss affiliate of a global biopharmaceutical company

The coronavirus disease 2019 (COVID-19) pandemic has been the defining public health emergency of our time. In Switzerland, messenger RNA (mRNA) vaccines were and still are widely utilized as a critical component of the Federal Office of Public Health (FOPH)’s preventative mitigation strategy. The d...

Descripción completa

Detalles Bibliográficos
Autores principales: Killeen, Tim, Kermer, Vanessa, Troxler Saxer, Rahel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683226/
https://www.ncbi.nlm.nih.gov/pubmed/38012751
http://dx.doi.org/10.1186/s40545-023-00652-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683226/
https://www.ncbi.nlm.nih.gov/pubmed/38012751
http://dx.doi.org/10.1186/s40545-023-00652-y

Ejemplares similares